Background: The H19 is a maternally expressed imprinted gene transcribing a long noncoding RNA (lncRNA), which has previously been reported to be involved in tumorigenesis and cancer progression. The aim of this study was to evaluate the associations between two lncRNA-H19 (rs3741219 T>C and rs217727 C>T) gene polymorphisms with the risk of breast cancer (BC).
| INTRODUC TI ON
Breast cancer (BC) is one of the most prominent causes of illness and death worldwide. BC is a malignant proliferation of epithelial cells that cover lacrimal ducts or lobules. Risk factors such as premenstrual meningitis, premature menopause, infertility, or age at the time of first birth may be responsible for one-third of cases of BC. With the improvement of early diagnosis and treatment regime, the mortality rate of BC significantly decreased. 1 Breast cancer is a complex disease and multifactorial process, in which a large number of epidemiological studies have been conducted to identify other risk factors for BC. 2 Previous genomic research has provided evidence to support single-nucleotide polymorphisms (SNP) in several genes associated with the risk of BC and contributed as carcinogenic agents. 3, 4 The total of SNPs has been identified in cancers; nearly 10 percent were associated with a change in the amino acid sequence, while a large proportion occurred in the coding or noncoding regions. 7 This highly questionable observation led to a wide range of research into the discovery of the function of noncoding sites and roles of the cancer development. These studies have led to the identification of lncRNA, which was transcribed from noncoding sites and may be increased the susceptibility of risk cancer. 8, 9 The lncRNA-H19 gene is a maternally expressed and coded a long noncoding RNA that has been reported previously involved in the tumor progression.
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LncRNA-H19 is a carcinogenic gene located at 11p15.5 of human chromosome, which is abnormally expressed in some types of tumors and acts as a tumor suppressor gene (TSG).
According to the evidence, it suggests that genetic changes in lncRNA-H19 play an important role in cancer development. 12, 13 To date, few studies have attempted to reveal the association between lncRNA-H19 gene polymorphism with the risk of BC. 16, 17 According to the previous findings, we assume that two SNPs in lncRNA-H19 may be related to the risk of BC in Iranian. However, the relationship between lncRNA-H19 polymorphism and BC remained unclear. The purpose of this investigation was to examine the association between two SNPs in lncRNA-H19 (rs3741219 T>C and rs217727 C>T) with the risk of BC.
| MATERIAL AND ME THODS

| Patients
In case-control investigation, we recruited a convenience periph- 
| Genotyping
For determination of genotype frequencies of two lncRNA-H19 gene polymorphisms, we used PCR-RFLP method and the following sequence of forward and reverse primers: 5´-CCCCCTGCGGCGGACGGTTG-3´ and 5´-GGCGTAATGGAATGCTTCAA-3´ for lncRNA-H19 (rs3741219) polymorphism, and 5´-ACTCACGAATCGGCTCTGGAAGGTG-3´
and 5´-ATGTGGTGGCTGGTGGTCAACGGT-3´ for lncRNA-H19
(rs217727) polymorphism. 16 The PCR of lncRNA-H19 (rs217727) gene polymorphism am- We obtained a PCR product with sizes of 247 and 434 bp for rs217727 and rs3741219, respectively. During product digestion, rs217727 (T allele: 247 bp, C allele: 221 + 26 bp) and rs3741219
(T allele: 342 + 92 bp, C allele: 301 + 92 + 41 bp) fragments were generated. The PCR product digested was separated on 3% agarose gel (Figures 1 and 2 ). We validated genotype frequencies by sequencing 10% of the examples through arbitrary selection.
| Statistical analysis
In order to determine the allele and genotype frequencies of lncRNA-H19 in two samples, the multivariate logistic regression and chisquare test were used, respectively. In addition, deductive variables and the difference ratio (OR) and confidence interval (CI = 95%) were used to estimate the association between the lncRNA-H19 polymorphism and probability of BC. Statistical analysis was performed by using SPSS 23.0 software package (SPSS Inc, Chicago, IL, USA). All the tests were two-sided, and a P-value under 0.05 was considered to be statistically significant. with the risk of BC (P = 0.065; OR = 0.967; 95% CI, 0.938-0.996).
In addition, our findings revealed a significant differences in allele The genotype and allele frequencies of lncRNA-H19 (rs3741219 T>C) gene polymorphism did not reveal a statistically significant difference between the two groups in three heredity models (P > 0.05; Table 1 ).
We also compared genotype frequencies for each polymorphism in case and control groups with clinicopathological parameters including, age, tumor stage (Table 2) , estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) receptor status (Table 3 ).
| D ISCUSS I ON
We examined the performance of two polymorphisms rs217727 and rs3741219 in lncRNA-H19 on susceptibility to BC in populations in East Azerbaijan Province, Iran. To get the best information, this study looked up at the role of nucleotide changes in lncRNA-H19 in BC carcinogenesis. Our findings revealed a significant differences in allele frequencies in lncRNA-H19 rs217727 C>T polymorphism between groups. On this basis, it can be suggested that the presence of rs217727 C>T polymorphism poses a risk of increased BC.
According to the latest knowledge by Xia et al, 16 reported that the nucleotide changes in lncRNA-H19 was associated with the risk of BC. The results showed that nonsignificant deviations from Hardy-Weinberg equilibrium for two polymorphisms were found among a total of 467 healthy women. Contradictory, our findings revealed that the rs217727 C>T polymorphism may be involved in BC carcinogenesis, whereas the genotyping results showed that the rs217727 was associated with a reduction in the risk of BC.
Previous studies have shown that lncRNAs can control the stages of the cell cycle, such as progression, cell death, invasion, and migration. The genetic variation in lncRNAs may alter the structures polymorphisms with the susceptibility of LC. They noted that the homozygous genotype of rs217727 was notably correlated with an elevated LC risk.
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Yang et al 12 studied the effect of four independent lncRNA-H19 SNPs (rs217727, rs2839698, rs3741216, and rs3741219) with gastric cancer risk in China population and showed that the T allele of rs217727 was associated with a higher risk of gastric cancer. Individuals with rs2839698 TT genotype showed a significant increase in gastric cancer susceptibility. Similarly, in the present study, we found a positive relationship between the rs217727 polymorphism and BC susceptibility. A nucleotide variation of lncRNA may be changing the structure and affects miRNA-lncRNA interaction. Increasing evidence suggests that lncRNAs can be directly regulated by miRNAs. 24 The effect of rs3741219 T>C lncRNA-H19 gene polymorphism and interaction of miRNA-lncRNA in BC cells remained unclear, and so further studies are needed to find the mechanism. Xia et al 16 showed that the release of miR-675 with the Our findings involve several significant points that should be mentioned. The present investigation assessed the initial nucleotide variations of lncRNA-H19 in relationship to BC susceptibility in Azeri-Turk Iranian population. In addition, in our survey, the all individuals matched on age and the racial characteristic identical.
In our investigation, we have evaluated the patient samples which all newly pathological diagnosed BC disease without obtaining any remedy regime. However, our consideration had several limitations including the analytical strength, the sample composition, and a large percentage of loss factors for some variables. In addition, we did not incorporate the effects of the lncRNA-H19 nucleotide changes in gene expression alteration and activity.
Therefore, somewhat investigations are profitable to confirm whether lncRNA-H19 variations could influence the pathogenesis of BC.
In conclusion, our findings demonstrate that the presence of rs217727 C>T polymorphism may play crucial roles in the pathogenesis of BC, whereas rs3741219 T>C variation cannot be promoting risk of BC susceptibility.
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